Anika Therapeutics to Present at the Tenth Annual Noble Financial Equity
Conference on January 20
Presentation to be Webcast Live at 11:00 a.m. ET
BEDFORD, Mass. -- January 9, 2014
Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in products for tissue
protection, healing and repair, based on hyaluronic acid (“HA”) technology,
today announced that its Chief Executive Officer, Dr. Charles Sherwood, and
Chief Commercial Officer, Carol Barnett, will be presenting at the Tenth
Annual Noble Financial Equity Conference on Monday, January 20, 2014 at 11:00
a.m. ET. The conference is being held in Sandpiper Bay, Florida.
An audio webcast of the presentation will be available live and may be
accessed via the “Investor Relations” section of Anika’s website at
www.anikatherapeutics.com. An archive of the presentation also will be
available on the website.
About Anika Therapeutics, Inc.
Headquartered in Bedford, Mass., Anika Therapeutics, Inc. develops,
manufactures and commercializes therapeutic products for tissue protection,
healing, and repair. These products are based on hyaluronic acid (HA), a
naturally occurring, biocompatible polymer found throughout the body. Anika’s
products range from orthopedic/joint health solutions led by Orthovisc^®, a
treatment for osteoarthritis of the knee; to surgical aids in the
anti-adhesion and ophthalmic fields. The company also offers aesthetic dermal
fillers for the correction of facial wrinkles. Anika’s Italian subsidiary,
Anika Therapeutics S.r.l., provides complementary HA products in
orthopedic/joint health and anti-adhesion, as well as therapeutics in areas
such as advanced wound treatment and ear, nose and throat care. Its
regenerative tissue technology advances Anika’s vision to offer therapeutic
products that go beyond pain relief to protect and restore damaged tissue.
Anika Therapeutics, Inc.
Charles H. Sherwood, Ph.D., CEO, 781-457-9000
Sylvia Cheung, CFO, 781-457-9000
Press spacebar to pause and continue. Press esc to stop.